Phenglutarimide hydrochloride

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

InformationFmoc-​Phe-​Lys(Boc)​-​PAB (FBN33428) is a hydrolyzable linker for making ADC conjugate which is used to make hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells.

InformationFmoc-​Phe-​Lys(Boc)​-​PAB (FBN33428) is a hydrolyzable linker for making ADC conjugate which is used to make hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells.

InformationFmoc-​Phe-​Lys(Boc)​-​PAB (FBN33428) is a hydrolyzable linker for making ADC conjugate which is used to make hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells.

General description Glyceryl tripalmitate is a simple saturated glyceride. It is a solid present majorly in palm and coconut oil.

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

GSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC 50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's diseaseIn VitroThe pyridine

GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, &gt:380,000-fold selectivity versus PDE1/2/3/5/6 and &gt:2500-fold selectivity against PDE4B versus PDE7A highly potent and selective inhibitor of

Application GYKI 52466 hydrochloride has been used as an &#945-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor selective antagonist in cell viability assays to evaluate the specificity of kainate (KA) effect on cerebellar

Application GYKI 52466 hydrochloride has been used as an &#945-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor selective antagonist in cell viability assays to evaluate the specificity of kainate (KA) effect on cerebellar

Application GYKI 52466 hydrochloride has been used as an &#945-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor selective antagonist in cell viability assays to evaluate the specificity of kainate (KA) effect on cerebellar